Premium
Treatment with alemtuzumab in a case of refractory primary cutaneous CD30‐negative CD8‐positive cytotoxic large T‐cell lymphoma
Author(s) -
Gutierrez Antonio,
Rodriguez Jose,
Ramos Rafael,
Gines Jordi,
Sampol Antonia,
Galmes Bernat,
Besalduch Joan
Publication year - 2004
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.2004.00232.x
Subject(s) - cd30 , medicine , cytotoxic t cell , cd52 , pathology , population , alemtuzumab , cd8 , granzyme , lymphoma , immunology , antigen , biology , perforin , antibody , biochemistry , environmental health , in vitro